INSMED INC (INSM) Stock Price, Quote, News and Overview
NASDAQ:INSM - Nasdaq - US4576693075 - Common Stock - Currency: USD
INSM Quote, Performance and Key Statistics
INSMED INC
NASDAQ:INSM (1/31/2025, 8:00:02 PM)
After market: 76.58 0 (0%)76.58
+0.29 (+0.38%)
The current stock price of INSM is 76.58 USD. In the past month the price increased by 10.92%. In the past year, price increased by 171.75%.
INSM Latest News, Press Releases and Analysis
Goldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been Alert
Insmed specializes in treatments for rare and serious diseases and is currently advancing its lead asset, brensocatib, a potential first-in-class therapy for bronchiectasis.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index looks at five stocks receiving increased attention from readers during the week and provides potential reason why.
Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference
--ARIKAYCE® (amikacin liposome inhalation suspension) Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...
Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...
INSM Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.11 | 324.98B | ||
| AMGN | AMGEN INC | 14.85 | 153.42B | ||
| GILD | GILEAD SCIENCES INC | 21.94 | 121.14B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 905.25 | 118.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.81 | 73.95B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.17B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.99B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.83B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.95B | ||
| NTRA | NATERA INC | N/A | 23.36B | ||
| BIIB | BIOGEN INC | 8.81 | 20.97B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.86B |
Related stock screener links
About INSM
Company Profile
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. The company is headquartered in Bridgewater, New Jersey and currently employs 912 full-time employees. The firm's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib and TPIP, as well as other early-stage research programs. Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), which is developing for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRSsNP). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil, which offers a differentiated product profile for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).
Company Info
INSMED INC
700 Us Highway 202/206
Bridgewater NEW JERSEY 08807 US
CEO: William H. Lewis
Employees: 912
Company Website: https://insmed.com/
Investor Relations: https://investor.insmed.com/index
Phone: 19089779900
INSM FAQ
What is the stock price of INSM?
The current stock price of INSM is 76.58 USD.
What is the symbol for INSMED INC stock?
The exchange symbol of INSMED INC is INSM and it is listed on the Nasdaq exchange.
On which exchange is INSM stock listed?
INSM stock is listed on the Nasdaq exchange.
Is INSM a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for INSM, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of INSM.
Does INSM stock pay dividends?
INSM does not pay a dividend.
When does INSM stock report earnings?
INSM will report earnings on 2025-02-20, after the market close.
What is the Price/Earnings (PE) ratio of INSM?
INSM does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.55).
What is the Short Interest ratio of INSM stock?
The outstanding short interest for INSM is 8.74% of its float.
INSM Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to INSM. When comparing the yearly performance of all stocks, INSM is one of the better performing stocks in the market, outperforming 96.29% of all stocks.
INSM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to INSM. While INSM seems to be doing ok healthwise, there are quite some concerns on its profitability.
INSM Financial Highlights
Over the last trailing twelve months INSM reported a non-GAAP Earnings per Share(EPS) of -5.55. The EPS increased by -5.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -42.1% | ||
| ROE | -178.79% | ||
| Debt/Equity | 2.03 |
INSM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to INSM. The Buy consensus is the average rating of analysts ratings from 24 analysts.
For the next year, analysts expect an EPS growth of -3.45% and a revenue growth 18.05% for INSM